Go to top of page

What's new

Man and woman working at an outdoor construction site

New resource to protect outdoor workers

15 July 2019

In Australia, skin cancer accounts for around 80% of all newly diagnosed cancers each year and UV radiation from the sun is one of the leading causes of skin cancer. With high UV radiation year-round in many parts of Australia, people who regularly work outside face a higher risk of developing cancer from sun exposure.

A woman shaking hands with a man in a wood-panelled room.

Dr Gillian Hirth elected Chair of United Nations Scientific Committee on the Effects of Atomic Radiation

9 July 2019

Dr Gillian Hirth, deputy CEO and Head of ARPANSA's Radiation Health Services Branch, has been elected as Chair of the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) for the 66th and 67th sessions

CEO of ARPANSA restricts production in the ANSTO Nuclear Medicine facility after accident

8 July 2019

Production of nuclear medicine at ANSTO’s Nuclear Medicine facility was halted on 21 June following an accident in which the hands of three workers were exposed to radiation.

Contamination event at ANSTO Nuclear Medicine facility

26 June 2019

On Friday 21 June 2019, ARPANSA was notified of a radiation contamination event at the Australian Nuclear Science and Technology Organisation (ANSTO) Nuclear Medicine (ANM) production facility in Lucas Heights, New South Wales.

human fingers turning a 4G cube into a 5G cube - the cube has writing '4G' and the writing is being moved to say '5G'

Misinformation about Australia’s 5G network

3 June 2019

ARPANSA is aware that there is a lot of concerning misinformation circulating throughout the community about the possible impacts of Australia’s planned roll-out of the 5G mobile network.

New emergency exposure guide

31 May 2019

We have published the Guide for Radiation Protection in Emergency Exposure Situations.

ARPANSA authorises ANSTO to commence routine production of molybdenum-99 in the ANM facility

27 May 2019

ARPANSA’s CEO, Dr Carl-Magnus Larsson has amended a licence issued to the Australian Nuclear Science and Technology Organisation (ANSTO) to operate the ANSTO Nuclear Medicine (ANM) facility.

Australian Pilots not at higher risk of melanoma than other Australians

22 May 2019

Recently, ARPANSA co-authored a new study which found that modern airline pilots registered in Australia, appear not to be at higher risk of developing invasive melanoma than the rest of the population.

ARPANSA expands ultraviolet radiation monitoring

16 May 2019

We’re pleased to be partnering with the Central Highlands Regional Council to establish Queensland’s fourth location for collection of real time ultraviolet (UV) data.

ARPANSA authorises limited production of molybdenum-99 in the ANM facility

8 April 2019

ARPANSA has granted the Australian Nuclear Science and Technology Organisation (ANSTO) an amended license to allow for the limited production of molybdenum-99 in order to sustain supply.

5G: the new generation of the mobile phone network and health

20 March 2019

At ARPANSA, we set the safety standard sets limits for exposure to radio frequency (RF) electromagnetic energy (EME) that is emitted by mobile phones and other wireless technologies. These limits are set well below levels at which harm to people may occur. The operating frequencies of the 5G network are included within the limits set by the ARPANSA safety standard.